SAN DIEGO, Oct. 23, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has garnered news coverage in leading international publication Men’s Health.
An Oct. 16, 2018, article on the Men’s Health website entitled, “I Tried 3 CBD Supplements for Workout Recovery. Here’s What Happened,” discusses the benefits a reporter at the publication experienced using HempMeds® Real Scientific Hemp Oil™ (RSHO™) and HempMeds® Active Relief Roll-On. In an effort to help readers better understand why they should consider using these products, the article also explains what cannabidiol (CBD) is and how it interacts with your body.
“We are excited to have this glowing testimonial for our CBD roll-on product, especially since we just announced our new 50-milligram version of it,” said HempMeds® President Todd Morrow. “We trust this coverage will help us expand our reach and introduce consumers to the many wellness benefits of our products.”
Men’s Health is an international online and print publication dedicated to showing men the practical and positive actions that can make their lives better. Regular features include information on fitness and grooming, health, food, drink and nutrition. Men’s Health boasts an audience of more than two million unique monthly readers.
“It’s incredible to see HempMeds recognized for its outstanding product lines,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “As the U.S. hemp industry continues to grow, we aim to stay at the forefront of the billion-dollar industry and credible reviews in trusted publications such as Men’s Health will certainly help us accomplish that goal.”
HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and also provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay.
About HempMeds®
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600
